These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7742001)

  • 1. Direct anti-atherosclerosis-related effects of garlic.
    Orekhov AN; Tertov VV; Sobenin IA; Pivovarova EM
    Ann Med; 1995 Feb; 27(1):63-5. PubMed ID: 7742001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro effect of garlic powder extract on lipid content in normal and atherosclerotic human aortic cells.
    Orekhov AN; Tertov VV
    Lipids; 1997 Oct; 32(10):1055-60. PubMed ID: 9358431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-atherosclerotic effects of garlic preparation in freeze injury model of atherosclerosis in cholesterol-fed rabbits.
    Sobenin IA; Andrianova IV; Lakunin KY; Karagodin VP; Bobryshev YV; Orekhov AN
    Phytomedicine; 2016 Oct; 23(11):1235-9. PubMed ID: 26739249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of allicin from garlic powder on serum lipids and blood pressure in rats fed with a high cholesterol diet.
    Ali M; Al-Qattan KK; Al-Enezi F; Khanafer RM; Mustafa T
    Prostaglandins Leukot Essent Fatty Acids; 2000 Apr; 62(4):253-9. PubMed ID: 10882191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of the aged garlic extract, 'Kyolic', on the development of experimental atherosclerosis.
    Efendy JL; Simmons DL; Campbell GR; Campbell JH
    Atherosclerosis; 1997 Jul; 132(1):37-42. PubMed ID: 9247357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of garlic on atherosclerosis.
    Orekhov AN; Grünwald J
    Nutrition; 1997; 13(7-8):656-63. PubMed ID: 9263259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneal macrophages: a model for detecting atherogenic potential in patients' blood serum.
    Tertov VV; Orekhov AN; Nikitina NA; Perova NV; Lyakishev AA; Serebrennikov SG; Gratziansky NA; Nechaev AS; Smirnov VN
    Ann Med; 1989 Dec; 21(6):455-9. PubMed ID: 2605038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis by which garlic suppresses atherosclerosis.
    Campbell JH; Efendy JL; Smith NJ; Campbell GR
    J Nutr; 2001 Mar; 131(3s):1006S-9S. PubMed ID: 11238806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of garlic oil in experimental cholesterol atherosclerosis.
    Jain RC; Konar DB
    Atherosclerosis; 1978 Feb; 29(2):125-9. PubMed ID: 646845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-density lipoproteins isolated from the blood of patients with coronary heart disease induce the accumulation of lipids in human aortic cells.
    Tertov VV; Orekhov AN; Martsenyuk ON; Perova NV; Smirnov VN
    Exp Mol Pathol; 1989 Jun; 50(3):337-47. PubMed ID: 2721653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesteryl ester transfer protein activity and atherogenic parameters in rabbits supplemented with cholesterol and garlic powder.
    Kwon MJ; Song YS; Choi MS; Park SJ; Jeong KS; Song YO
    Life Sci; 2003 May; 72(26):2953-64. PubMed ID: 12706483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Garlic preparations for prevention of atherosclerosis.
    Berthold HK; Sudhop T
    Curr Opin Lipidol; 1998 Dec; 9(6):565-9. PubMed ID: 9868592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of alcoholic extract of garlic in atherosclerosis.
    Jain RC
    Am J Clin Nutr; 1978 Nov; 31(11):198203. PubMed ID: 717269
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of garlic supplementation to cholesterol-rich diet on development of atherosclerosis in rabbits.
    Mirhadi SA; Singh S; Gupta PP
    Indian J Exp Biol; 1991 Feb; 29(2):162-8. PubMed ID: 1869301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Direct antiatherogenic effect of garlic].
    Orekhov AN; Tertov VV; Sobenin IA; Pivovarova EM; Medvedeva LA; Skalbe TA
    Biull Eksp Biol Med; 1996 Jun; 121(6):695-7. PubMed ID: 9035770
    [No Abstract]   [Full Text] [Related]  

  • 16. Beta-blockers: propranolol, metoprolol, atenolol, pindolol, alprenolol and timolol, manifest atherogenicity on in vitro, ex vivo and in vivo models. Elimination of propranolol atherogenic effects by papaverine.
    Orekhov AN; Andrianova IV; Rekhter MD; Tertov VV; Andreeva ER; Ragimov SE; Mironov AA
    Atherosclerosis; 1992 Jul; 95(1):77-85. PubMed ID: 1353674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of garlic feeding on regression of experimental atherosclerosis in rabbits.
    Bordia A; Verma SK
    Artery; 1980; 7(5):428-37. PubMed ID: 7213027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sera containing elevated nonesterified fatty acids from patients with angiographically documented coronary atherosclerosis cause marked lipid accumulation in cultured human arterial smooth muscle-derived cells.
    Laughton CW; Ruddle DL; Bedord CJ; Alderman EL
    Atherosclerosis; 1988 Apr; 70(3):233-46. PubMed ID: 3365291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cholesterol-containing circulating immune complexes--a component of the blood serum in patients with ischemic heart disease that determines its atherogenic properties].
    Tertov VV; Kacharava AG; Saiadian KhS; Serebrennikov SG; Liakishev AA; Kozlov SG; Gratsianskiĭ NA; Rogova EM; Bocharova OI; Orekhov AN
    Kardiologiia; 1989 Aug; 29(8):35-8. PubMed ID: 2479794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between cholesterol content in circulating immune complexes and atherogenic properties of CHD patients' serum manifested in cell culture.
    Tertov VV; Orekhov AN; Sayadyan KS; Serebrennikov SG; Kacharava AG; Lyakishev AA; Smirnov VN
    Atherosclerosis; 1990 Apr; 81(3):183-9. PubMed ID: 2350370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.